Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery
Crossref DOI link: https://doi.org/10.1007/s00595-014-1017-y
Published Online: 2014-08-26
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Adachi, T.
Hinoi, T.
Egi, H.
Shimomura, M.
Ohdan, H.
Text and Data Mining valid from 2014-08-26
